Laboratorios Farmaceuticos ROVI SA

Common Name

Laboratorios Farmaceuticos ROVI

Country

Spain

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

2,197

Ticker

ROVI

Exchange

BOLSA DE MADRID

Website

www.rovi.es

Description

Laboratorios Farmaceuticos Rovi S.A. is an established pharmaceutical and biotechnology company based in Spain, celebrated for its expansive portfolio of drug development and production. The primary f... Show more

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Laboratorios Farmaceuticos ROVI's EU Taxonomy Data Preview

In 2024, Laboratorios Farmaceuticos ROVI was subject to the Corporate Sustainability Reporting Directive (CSRD)'s requirements, which mandated the company to publish EU Taxonomy disclosures.

The company reported the eligibility and alignment of Turnover, Capital Expenditure (CAPEX) and Operating Expenditure (OPEX) with the EU Taxonomy, helping assess the extent to which its business activities align with Europe's environmental sustainability goals.

Laboratorios Farmaceuticos ROVI has also provided an activity-level breakdown of its EU Taxonomy disclosures. This granular reporting enhances transparency around which economic activities of Laboratorios Farmaceuticos ROVI are considered environmentally sustainable and contribute to at least one of the six environmental objectives defined under the EU Taxonomy framework.

turnoveropexcapex

Metric (tonnes)	2025	2024	2023	2022 - 2017
Total Taxonomy Aligned A1 Turnover Portion of total company turnover generated from economic activities that are eligible under the EU Taxonomy and meet all alignment requirements, including substantial contribution, Do No Significant Harm (DNSH), and minimum safeguards.	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data.	Data available for purchase 0000000
Total Taxonomy Eligible A Turnover Total turnover of the company associated with activities considered eligible under the EU Taxonomy, regardless of whether they meet alignment criteria.	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data. ^a	Copy restricted. Please purchase to unlock this data. ^b	Data available for purchase 0000000
Total Taxonomy Non-Eligible B Turnover Total turnover of the company associated with activities that are not listed as eligible under the EU Taxonomy.	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data. ^a	Copy restricted. Please purchase to unlock this data. ^b	Data available for purchase 0000000

Metric (tonnes)	2025	2024	2023	2022 - 2017
Total Taxonomy Aligned A1 Opex Portion of total company OPEX generated from economic activities that are eligible under the EU Taxonomy and meet all alignment requirements, including substantial contribution, Do No Significant Harm (DNSH), and minimum safeguards.	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data. ^a	Copy restricted. Please purchase to unlock this data. ^b	Data available for purchase 0000000
Total Taxonomy Eligible A Opex Total OPEX of the company associated with activities considered eligible under the EU Taxonomy, regardless of whether they meet alignment criteria.	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data. ^a	Copy restricted. Please purchase to unlock this data. ^b	Data available for purchase 0000000
Total Taxonomy Non-Eligible B Opex Total OPEX of the company associated with activities that are not listed as eligible under the EU Taxonomy.	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data. ^a	Copy restricted. Please purchase to unlock this data. ^b	Data available for purchase 0000000
Activity Level Taxonomy Aligned A1 Opex (4 activities)
7.3 CCM/CCA - Installation, maintenance and repair of energy efficiency equipment 7.3 CCM/CCA - Installation, maintenance and repair of energy efficiency equipment	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data. ^a	Copy restricted. Please purchase to unlock this data. ^b	Data available for purchase 0000000
7.4 CCM/CCA - Installation, maintenance and repair of charging stations for electric vehicles in buildings (and parking spaces attached to buildings) 7.4 CCM/CCA - Installation, maintenance and repair of charging stations for electric vehicles in buildings (and parking spaces attached to buildings)	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data. ^a	Copy restricted. Please purchase to unlock this data.	Data available for purchase 0000000
7.5 CCM/CCA - Installation, maintenance and repair of instruments and devices for measuring, regulation and controlling energy performance of buildings 7.5 CCM/CCA - Installation, maintenance and repair of instruments and devices for measuring, regulation and controlling energy performance of buildings	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data. ^a	Copy restricted. Please purchase to unlock this data. ^b	Data available for purchase 0000000
7.6 CCM/CCA - Installation, maintenance and repair of renewable energy technologies 7.6 CCM/CCA - Installation, maintenance and repair of renewable energy technologies	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data. ^a	Copy restricted. Please purchase to unlock this data. ^b	Data available for purchase 0000000

Metric (tonnes)	2025	2024	2023	2022 - 2017
Total Taxonomy Aligned A1 Capex Portion of total company CAPEX generated from economic activities that are eligible under the EU Taxonomy and meet all alignment requirements, including substantial contribution, Do No Significant Harm (DNSH), and minimum safeguards.	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data. ^a	Copy restricted. Please purchase to unlock this data. ^b	Data available for purchase 0000000
Total Taxonomy Eligible A Capex Total CAPEX of the company associated with activities considered eligible under the EU Taxonomy, regardless of whether they meet alignment criteria.	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data. ^a	Copy restricted. Please purchase to unlock this data. ^b	Data available for purchase 0000000
Total Taxonomy Non-Eligible B Capex Total CAPEX of the company associated with activities that are not listed as eligible under the EU Taxonomy.	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data. ^a	Copy restricted. Please purchase to unlock this data. ^b	Data available for purchase 0000000
Activity Level Taxonomy Aligned A1 Capex (4 activities)
7.3 CCM/CCA - Installation, maintenance and repair of energy efficiency equipment 7.3 CCM/CCA - Installation, maintenance and repair of energy efficiency equipment	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data. ^a	Copy restricted. Please purchase to unlock this data. ^b	Data available for purchase 0000000
7.4 CCM/CCA - Installation, maintenance and repair of charging stations for electric vehicles in buildings (and parking spaces attached to buildings) 7.4 CCM/CCA - Installation, maintenance and repair of charging stations for electric vehicles in buildings (and parking spaces attached to buildings)	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data. ^a	Copy restricted. Please purchase to unlock this data. ^b	Data available for purchase 0000000
7.5 CCM/CCA - Installation, maintenance and repair of instruments and devices for measuring, regulation and controlling energy performance of buildings 7.5 CCM/CCA - Installation, maintenance and repair of instruments and devices for measuring, regulation and controlling energy performance of buildings	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data. ^a	Copy restricted. Please purchase to unlock this data. ^b	Data available for purchase 0000000
7.6 CCM/CCA - Installation, maintenance and repair of renewable energy technologies 7.6 CCM/CCA - Installation, maintenance and repair of renewable energy technologies	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data. ^a	Copy restricted. Please purchase to unlock this data. ^b	Data available for purchase 0000000

Verified Sources Behind Laboratorios Farmaceuticos ROVI’s EU Taxonomy Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Laboratorios Farmaceuticos ROVI’s data sources below and access millions more through our Disclosure Search.

a. Laboratorios Farmaceuticos ROVI's Sustainability Report 2024

b. Laboratorios Farmaceuticos ROVI's Integrated Report 2023

c. Laboratorios Farmaceuticos ROVI's Integrated Report 2022

Insights into Laboratorios Farmaceuticos ROVI's CAPEX from Sustainable Activities

In 2024, Laboratorios Farmaceuticos ROVI reported EU Taxonomy-eligible CAPEX of EUR 47.20 million,representing 71.99% of its total CAPEX. Of this amount, EUR 832,357 of Laboratorios Farmaceuticos ROVI's CAPEX was classified as EU Taxonomy-aligned, indicating that 1.27% of the company's investments were directed toward economic activities that substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS).^a

Laboratorios Farmaceuticos ROVI's Taxonomy-Eligible Capex Over Time

Total Taxonomy Aligned A1 Capex
Total Taxonomy Eligible but Not Aligned A2 Capex

Have Laboratorios Farmaceuticos ROVI's increased its investment in sustainable activities over time?

Since 2022, Laboratorios Farmaceuticos ROVI's taxonomy-aligned capital expenditure (CAPEX)increased by 48.07%,pointing to a long-term shift toward greater investment in environmentally sustainable activities recognized under the EU Taxonomy.^{a, c}

Compared to the previous year (2023), Laboratorios Farmaceuticos ROVI's taxonomy-aligned CAPEX decreased by 40.84%,suggesting that Laboratorios Farmaceuticos ROVI may have scaled back investments in sustainable projects, reprioritized its capital deployment, or reduced transparency in its taxonomy-aligned disclosures.^{a, b}

How much of Laboratorios Farmaceuticos ROVI's capital expenditure (CAPEX) is eligible under the EU Taxonomy?

In 2024, Laboratorios Farmaceuticos ROVI reported that EUR 47.20 million of its capital expenditure (CAPEX) was eligible under the EU Taxonomy, representing 71.99% of the company's total CAPEX. Of this amount, EUR 832,357 (1.27% of total CAPEX) was classified as Taxonomy-aligned. This means that 70.72% of Laboratorios Farmaceuticos ROVI's CAPEX is eligible but not aligned, indicating that these investments either did not meet the technical screening criteria, failed to comply with the Do No Significant Harm (DNSH) requirements, or lacked evidence of meeting the Minimum Safeguards (MSS).^a

How much of Laboratorios Farmaceuticos ROVI's eligible CAPEX is aligned with the EU Taxonomy?

In 2024, Laboratorios Farmaceuticos ROVI reported that EUR 832,357 of its CAPEX was aligned under the EU Taxonomy, representing 1.27% of its total capital investment.^a

This low alignment reflects that Laboratorios Farmaceuticos ROVI is beginning to transition its capital allocation toward greener investments, but still retains substantial opportunities for further alignment with sustainability goals.

Laboratorios Farmaceuticos ROVI's Eligibility & Alignment Overview

Laboratorios Farmaceuticos ROVI's Contribution to Environmental Objectives

Total Taxonomy Aligned A1 Capex
Total Taxonomy Eligible but Not Aligned A2 Capex

How is Laboratorios Farmaceuticos ROVI's taxonomy-aligned CAPEX distributed across the EU environmental objectives?

In 2024, Laboratorios Farmaceuticos ROVI reported that its taxonomy-aligned capital expenditure (CAPEX) was distributed across the following EU environmental objectives^a:

Climate Change Mitigation: 1.27%
Climate Change Adaptation: 0%
Sustainable Use and Protection of Water and Marine Resources: 0%
Transition to a Circular Economy: 0%
Pollution Prevention and Control: 0%
Protection and restoration of biodiversity and ecosystems: 0%

How much Laboratorios Farmaceuticos ROVI is investing in climate-related solutions?

In 2024, Laboratorios Farmaceuticos ROVI allocated EUR 832,083 of its CAPEX to activities contributing to the EU Taxonomy's climate-related objectives (Climate Change Mitigation and Climate Change Adaptation). This represented 1.27% of the company's total capital expenditure,indicating that Laboratorios Farmaceuticos ROVIhas only marginally directed its capital expenditure toward climate-related activities, suggesting limited alignment with climate objectives.^a

Insights into Laboratorios Farmaceuticos ROVI's OPEX from Sustainable Activities

In 2024, Laboratorios Farmaceuticos ROVI reported EU Taxonomy-eligible OPEX of EUR 9.93 million,representing 26.67% of its total operating expenses (OPEX). Of this amount, EUR 146,883 of Laboratorios Farmaceuticos ROVI's OPEX was classified as EU Taxonomy-aligned, indicating that 0.39% of the company's operating expenses were directed toward economic activities that substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS).^a

Laboratorios Farmaceuticos ROVI's Taxonomy-Eligible Opex Over Time

Total Taxonomy Aligned A1 Opex
Total Taxonomy Eligible but Not Aligned A2 Opex

Have Laboratorios Farmaceuticos ROVI's increased its spending in sustainable activities over time?

Since 2022, Laboratorios Farmaceuticos ROVI's taxonomy-aligned operating expenditure (OPEX)increased by 629.63%,pointing to a long-term trend of increased spending on environmentally sustainable operations and services recognized under the EU Taxonomy.^{a, c}

Compared to the previous year (2023), Laboratorios Farmaceuticos ROVI's taxonomy-aligned OPEX increased by 189.71%,highlighting Laboratorios Farmaceuticos ROVI's growing commitment to funding sustainable operations or improving how such expenses are classified and reported under the EU Taxonomy.^{a, b}

How much of Laboratorios Farmaceuticos ROVI's operational expenditure (OPEX) is eligible under the EU Taxonomy?

In 2024, Laboratorios Farmaceuticos ROVI reported that EUR 9.93 million of its operational expenditure (OPEX) was eligible under the EU Taxonomy, representing 26.67% of the company's total OPEX. Of this amount, EUR 146,883 (0.39% of total OPEX) was classified as Taxonomy-aligned. This means that 26.27% of Laboratorios Farmaceuticos ROVI's OPEX is eligible but not aligned, indicating that these expenditures either did not meet the technical screening criteria, failed to comply with the Do No Significant Harm (DNSH) requirements, or lacked evidence of meeting the Minimum Safeguards (MSS).^a

How much of Laboratorios Farmaceuticos ROVI's eligible OPEX is aligned with the EU Taxonomy?

In 2024, Laboratorios Farmaceuticos ROVI reported that EUR 146,883 of its OPEX was aligned under the EU Taxonomy, representing 0.39% of its total operational expenditure.^a

This low alignment reflects limited operational focus on green activities, suggesting that sustainability considerations have yet to be fully integrated into core operating processes.

Laboratorios Farmaceuticos ROVI's Eligibility & Alignment Overview

Laboratorios Farmaceuticos ROVI's Contribution to Environmental Objectives

Total Taxonomy Aligned A1 Opex
Total Taxonomy Eligible but Not Aligned A2 Opex

How is Laboratorios Farmaceuticos ROVI's taxonomy-aligned OPEX distributed across the EU environmental objectives?

In 2024, Laboratorios Farmaceuticos ROVI reported that its taxonomy-aligned operational expenditure (OPEX) was distributed across the following EU environmental objectives^a:

Climate Change Mitigation: 0.39%
Climate Change Adaptation: 0%
Sustainable Use and Protection of Water and Marine Resources: 0%
Transition to a Circular Economy: 0%
Pollution Prevention and Control: 0%
Protection and restoration of biodiversity and ecosystems: 0%

How much of Laboratorios Farmaceuticos ROVI's operational budget supports climate-related solutions?

In 2024, Laboratorios Farmaceuticos ROVI allocated EUR 146,757 of its OPEX to activities contributing to the EU Taxonomy's climate-related objectives (Climate Change Mitigation and Climate Change Adaptation). This represented 0.39% of the company's total OPEX,indicating that Laboratorios Farmaceuticos ROVIhas only a limited share of operational expenditure aligned with climate goals, signaling early-stage or minimal integration of climate objectives into its routine activities.^a

Want Full Access to Laboratorios Farmaceuticos ROVI's EU Taxonomy Dataset?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Laboratorios Farmaceuticos ROVI SA

Laboratorios Farmaceuticos ROVI's EU Taxonomy Data Preview

Verified Sources Behind Laboratorios Farmaceuticos ROVI’s EU Taxonomy Data

Insights into Laboratorios Farmaceuticos ROVI's Revenues from Sustainable Activities

Insights into Laboratorios Farmaceuticos ROVI's CAPEX from Sustainable Activities

Laboratorios Farmaceuticos ROVI's Taxonomy-Eligible Capex Over Time

Have Laboratorios Farmaceuticos ROVI's increased its investment in sustainable activities over time?

How much of Laboratorios Farmaceuticos ROVI's capital expenditure (CAPEX) is eligible under the EU Taxonomy?

How much of Laboratorios Farmaceuticos ROVI's eligible CAPEX is aligned with the EU Taxonomy?

Laboratorios Farmaceuticos ROVI's Eligibility & Alignment Overview

Laboratorios Farmaceuticos ROVI's Contribution to Environmental Objectives

How is Laboratorios Farmaceuticos ROVI's taxonomy-aligned CAPEX distributed across the EU environmental objectives?

How much Laboratorios Farmaceuticos ROVI is investing in climate-related solutions?

Insights into Laboratorios Farmaceuticos ROVI's OPEX from Sustainable Activities

Laboratorios Farmaceuticos ROVI's Taxonomy-Eligible Opex Over Time

Have Laboratorios Farmaceuticos ROVI's increased its spending in sustainable activities over time?

How much of Laboratorios Farmaceuticos ROVI's operational expenditure (OPEX) is eligible under the EU Taxonomy?

How much of Laboratorios Farmaceuticos ROVI's eligible OPEX is aligned with the EU Taxonomy?

Laboratorios Farmaceuticos ROVI's Eligibility & Alignment Overview

Laboratorios Farmaceuticos ROVI's Contribution to Environmental Objectives

How is Laboratorios Farmaceuticos ROVI's taxonomy-aligned OPEX distributed across the EU environmental objectives?

How much of Laboratorios Farmaceuticos ROVI's operational budget supports climate-related solutions?

Explore Peer Companies

Faes Farma SA

Almirall SA

Grifols SA

Atrys Health SA

Clinica Baviera SA

Pharma Mar SA